SCHEMBL7835686

SCHEMBL7835686

CSc1ccccc1C(CC(=O)OC(C)(C)C)NC(=O)CNC(=O)c1cccc(NC(=N)N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 2/20 0.39
ITGB3 P05106 4/20 0.38
ITGAV P06756 4/20 0.38
ITGB6 P18564 4/20 0.38
ITGB1 P05556 2/20 0.38
ITGA5 P08648 2/20 0.38
ITGB5 P18084 2/20 0.38
ITGB8 P26012 2/20 0.38
ITGA8 P53708 2/20 0.38
PRMT5 O14744 1/20 0.38
WDR77 Q9BQA1 1/20 0.38
ALDH1A1 P00352 1/20 0.37
CASR P41180 1/20 0.36
F2 P00734 3/20 0.36
TMPRSS6 Q8IU80 1/20 0.36
HTT P42858 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GPR139 Q6DWJ6 4/20 0.35
F10 P00742 1/20 0.35
F7 P08709 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6773735 0.86 TP53 (0.39) PTPRCITGB3ITGAVITGB6ITGB1
SCHEMBL6778195 0.84 ITGB3 (0.43) ITGB3ITGAVITGB1ITGA5CASR
SCHEMBL7838359 0.83 PTPRC (0.38) PTPRCITGB3ITGAVITGB6ITGB1
SCHEMBL6778844 0.82 PTPRC (0.37) PTPRCITGB3ITGAVITGB6ITGB1
SCHEMBL7835946 0.77 ITGB3 (0.51) ITGB3ITGAVITGB6ITGB1ITGA5
SCHEMBL6782067 0.76 ITGB3 (0.55) ITGB3ITGAVITGB6ITGB1ITGA5
SCHEMBL6776952 0.76 ITGB3 (0.49) ITGB3ITGAVITGB6ITGB1ITGA5
SCHEMBL27486478 0.76 GPR139 (0.44) ITGB3ITGAVITGB1ITGA5F2
SCHEMBL3839471 0.76 GPR139 (0.47) ITGB3ITGAVITGB1ITGA5F2
SCHEMBL7832122 0.76 ITGB3 (0.42) ITGB3ITGAVITGB6ITGB1ITGA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850221-B1 META-GUANIDINE, UREA, THIOUREA OR AZACYCLIC AMINO BENZOIC ACID DERIVATIVES AS INTEGRIN ANTAGONISTS SEARLE & CO (US) 2001-07-18 EP disclosed
US-6028223-A AN INTEGRIN ANTAGONISTS TREATING BONE DISORDER, PERIODONTAL DISEASE, OSTEOPOROSIS, HUMORAL HYPERCALCEMIA OF MALIGNANCY, PAGET'S DISEASE, TUMOR ANGIOGENESIS, DIABETIC RETINOPATHY, ARTHRITIS, SMOOTH MUSCLE CELL MIGRATION AND RESTENOSIS G. D. SEARLE & CO. (US) 2000-02-22 US disclosed